24小时热门版块排行榜    

查看: 1538  |  回复: 38
当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖

幽若芊芊

金虫 (小有名气)


[交流] 【2015-03-27】【EI/ISTP】SCI期刊 征稿(多模态分子影像)IF:2.7

是否Ei/ISTP收录:
Ei/ISTP双收录
截稿日期:
2015年3月27日

SCI期刊 征稿(多模态分子影像)IF:2.7         
BioMed Research International是SCI收录期刊,主要刊载面向医学与生命科学领域方面的研究及进展。最新JCR影响因子为2.7
本期特辑的主题的多模态分子影像,截稿时间为2015年3月27日,投稿具体要求和页面如下:https://www.hindawi.com/journals/bmri/si/538402/cfp/

Multimodality Molecular Imaging
Call for Papers

Multimodal molecular imaging can offer a synergistic improvement of diagnostic ability over a single imaging modality. Recent development of hybrid imaging systems has profoundly impacted the pool of available multimodal imaging probes. A combination of multifunctional molecular probes such as biomolecules, polymers, and nanoparticles continues to increase functionality for in vivo multimodal imaging and therapeutic agents. In this special issue, we take a great interest in studies on multimodal molecular imaging.
Particularly, papers that deal with functional investigations of multimodal molecular imaging are welcome. Cutting-edge reviews relevant to this topic are also considered. This special issue will bring our communities the most recent ideas and advances in this field.

Potential topics include, but are not limited to:

Multimodality molecular imaging and targeted therapy
Nanotechnology for multimodality molecular imaging
In vivo application for multimodal molecular imaging of tumor
Authors can submit their manuscripts via the Manuscript Tracking System at https://mts.hindawi.com/submit/jo ... ular.imaging/mica/.

Manuscript Due        Friday, 27 March 2015
First Round of Reviews        Friday, 19 June 2015
Publication Date        Friday, 14 August 2015
Lead Guest Editor

Xin Zhou, Wuhan Institute of Physics and Mathematics, Wuhan, China
Guest Editors
Michael T. McMahon, Johns Hopkins University, Baltimore, USA
Shaoqun Zeng, Huazhong University of Science and Technology, Wuhan, China

[ Last edited by Paulwolf on 2015-3-7 at 08:41 ]
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

hulkmiao

金虫 (著名写手)



幽若芊芊(金币+1): 谢谢参与
good

[ 发自手机版 https://muchong.com/3g ]
28楼2015-03-19 08:01:13
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
查看全部 39 个回答
简单回复
numerical11楼
2015-03-07 20:19   回复  
幽若芊芊(金币+1): 谢谢参与
普通表情 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[考博] 找导师 +5 yuanjiabao 2026-08-29 6/300 2026-08-30 11:52 by zhouyanli11
[博后之家] 售SCI文章,我:8O.5.5.1O.54,科目全,可十急 +8 ASdOkHsho7FD 2026-08-28 9/450 2026-08-30 11:40 by l0VvVHGBGRLv
[公派出国] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +5 ASdOkHsho7FD 2026-08-28 6/300 2026-08-30 11:18 by l0VvVHGBGRLv
[基金申请] 我就是申请一个面上项目而已,这评审意见是按照杰青的条件评的吧? +6 gouxfjh 2026-08-28 11/550 2026-08-30 07:57 by gouxfjh
[硕博家园] 售SCI一区T0P文章,我:8O.55.1.O.54,科目全,可伽急 +3 G6APbkg8SA6w 2026-08-29 4/200 2026-08-30 07:17 by ZPa0EcMwuECS
[考博] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +3 gy1nBQXYQJqL 2026-08-29 5/250 2026-08-30 07:05 by ZPa0EcMwuECS
[硕博家园] 售SCI一区T0P文章,我:8.O.55.1.O.54,科目齐全,可+急 +3 gy1nBQXYQJqL 2026-08-29 6/300 2026-08-30 06:22 by ZPa0EcMwuECS
[硕博家园] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +6 ASdOkHsho7FD 2026-08-28 11/550 2026-08-30 06:00 by ZPa0EcMwuECS
[教师之家] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +5 ASdOkHsho7FD 2026-08-28 8/400 2026-08-30 05:48 by ZPa0EcMwuECS
[考研] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +4 G6APbkg8SA6w 2026-08-29 5/250 2026-08-30 02:40 by ZPa0EcMwuECS
[基金申请] 国社科申报系统有变化 +3 kynobel 2026-08-23 3/150 2026-08-29 21:57 by 余韵清
[教师之家] 导师吐槽:我怎么摊上了这么个极品研究生! +9 苏东坡二世 2026-08-23 9/450 2026-08-29 14:41 by hustersqt
[基金申请] 国自然评审意见 +13 wangmingqi 2026-08-28 19/950 2026-08-29 10:22 by Poppy1104
[基金申请] 怎么查啊 +6 huang1991js 2026-08-26 6/300 2026-08-28 08:42 by winsaint
[基金申请] 申请删除本帖 +6 lyz123lyz 2026-08-27 7/350 2026-08-27 17:31 by 宁静致远sy
[基金申请] 我不理解! +15 Edward_pc 2026-08-26 23/1150 2026-08-26 20:34 by zzuzxg
[基金申请] 2026年8月25日国自然放榜前突然收到列入评审专家邮件,有关系吗? +25 木水思豆 2026-08-25 28/1400 2026-08-26 14:53 by draco1987
[基金申请] 出来了 +9 trojank 2026-08-26 9/450 2026-08-26 14:25 by 宝贝虫子
[基金申请] 为什么国自然不能直接公布 +4 bjdxyxy 2026-08-26 4/200 2026-08-26 13:12 by qingmu1201
[基金申请] 没有任何消息-是不是就凉了 +9 图啦图啦 2026-08-24 10/500 2026-08-25 11:59 by 南海小哥
信息提示
请填处理意见